Search

everythinglearnresearchcommunity

for

Search:↓

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Taking Saw palmetto and Pygeum africana can change the levels of certain steroids in urine, which could cause confusion in doping tests.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Monitoring steroid hormones in blood can better detect testosterone doping.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

New genes and pathways are important for testosterone production and male sexual development.

Finasteride reduces hair growth and is safe for women with excessive hair.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The method effectively detects banned substances in urine for sports antidoping.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.